Tumor cells with transferred astrocytic mitochondria showed higher proliferation capacity (bigger proportion of tumor cells in G2/M phase of cell cycle) and capability to self-renew (higher expression of SOX2 and OCT4) compared with GBM cells without mitochondria transfer. This evidence concerns the gene SOX2 and glioblastoma.